- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jan 14, 2022
Highlights
- Market Cap
- $3.40M
- Enterprise Value
- -$3.12M
- EPS (TTM)
- -$3.11
- Total Revenue (TTM)
- $16.57K
- Gross Profit (TTM)
- -$324.16K
- EBITDA (TTM)
- -$6.37M
- Year Range
- $0.97 - $7.91
- ROA (TTM)
- -69.58%
- ROE (TTM)
- -74.70%
- Avg. Volume (1M)
- 84K
- Avg. Volume Value (1M)
- $134.49K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CDIO Performance Chart
Cardio Diagnostics Holdings Inc (CDIO) is down 39.5% since the beginning of the year. At $2 per share, CDIO is trading 79.3% below its 52-week high of $8.
Loading charts...
Compare this symbol against anything
Returns By Period
Cardio Diagnostics Holdings Inc (CDIO) has returned -39.48% so far this year and -57.73% over the past 12 months.
Cardio Diagnostics Holdings Inc
- 1D
- 5.13%
- 1M
- -17.59%
- 6M
- 13.10%
- YTD
- -39.48%
- 1Y
- -57.73%
- 3Y*
- -61.98%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -68.03%
Benchmark (S&P 500 Index)
- 1D
- 1.48%
- 1M
- 1.57%
- 6M
- 8.95%
- YTD
- 11.03%
- 1Y
- 21.84%
- 3Y*
- 19.28%
- 5Y*
- 11.54%
- 10Y*
- 13.29%
- ALL TIME*
- 8.11%
CDIO Monthly Returns History
Based on dividend-adjusted daily data since Jan 14, 2022, CDIO's average daily return is +0.08%, while the average monthly return is +11.06%. At this rate, an investment would double in approximately 0.6 years.
Historically, 48% of months were positive and 52% were negative. The best month was Nov 2023 with a return of +576.4%, while the worst month was Oct 2022 at -71.7%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 4 months.
On a daily basis, CDIO closed higher 37% of trading days. The best single day was Feb 28, 2023 with a return of +158.5%, while the worst single day was May 8, 2025 at -47.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -44.28% | 333.77% | -70.23% | -8.21% | 5.59% | 15.87% | -28.77% | 5.13% | -39.48% | ||||
| 2025 | -52.10% | 2.30% | -26.55% | 28.73% | -68.69% | -9.77% | 15.00% | -7.97% | 5.25% | 0.75% | -28.71% | -5.90% | -90.15% |
| 2024 | -12.45% | -25.69% | -12.35% | -51.76% | 1.12% | -20.60% | -18.18% | -16.67% | -40.53% | 25.56% | 8.57% | 201.64% | -63.17% |
| 2023 | -9.43% | 259.38% | 13.33% | -40.66% | -35.78% | -20.13% | 1.68% | -54.55% | -38.17% | -11.29% | 576.39% | 22.06% | 134.91% |
| 2022 | 0.41% | 0.20% | 0.30% | 0.20% | 0.10% | 0.10% | 0.50% | 0.20% | 0.40% | -71.71% | -22.18% | -52.04% | -89.18% |
Benchmark Metrics
Cardio Diagnostics Holdings Inc has an annualized alpha of 5.02%, beta of 1.18, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since January 14, 2022.
- This stock participated in 37.25% of S&P 500 Index downside but only -143.90% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 5.02%
- Beta
- 1.18
- R²
- 0.01
- Upside Capture
- -143.90%
- Downside Capture
- 37.25%
Return for Risk
Risk / Return Rank
CDIO ranks 25 for risk / return — above 25% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Cardio Diagnostics Holdings Inc (CDIO) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CDIO | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.10 | ||
| Sortino ratioReturn per unit of downside risk | -2.26 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.31 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | -0.73 | 2.41 | -3.14 |
| Martin ratioReturn relative to average drawdown | -1.12 | 10.22 | -11.34 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Cardio Diagnostics Holdings Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cardio Diagnostics Holdings Inc was 99.66%, occurring on Feb 5, 2026. The portfolio has not yet recovered.
The current Cardio Diagnostics Holdings Inc drawdown is 99.47%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.66%Feb 2026 | 3y 3mo | — | 3y 9moOct 2022 - now | — |
-0.61%Jan 2022 | 1d | 1mo 11d | 1mo 12dJan 2022 - Mar 2022 | Bear market2022 |
-0.20%May 2022 | 1d | 2d | 2dMay 2022 - Jun 2022 | Bear market2022 |
-0.20%Jun 2022 | 1d | 22d | 22dJun 2022 - Jul 2022 | Bear market2022 |
-0.15%Apr 2022 | 1d | 1d | 1dApr 2022 - Apr 2022 | Bear market2022 |
Drawdown Indicators
| CDIO | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.66% | -56.78% | -42.88% |
Max Drawdown (1Y)Largest decline over 1 year | -79.08% | -9.10% | -69.98% |
Max Drawdown (3Y)Largest decline over 3 years | -98.86% | -18.90% | -79.96% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.47% | -0.12% | -99.35% |
Average DrawdownAverage peak-to-trough decline | -76.22% | -10.70% | -65.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 51.46% | 2.14% | +49.32% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cardio Diagnostics Holdings Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Cardio Diagnostics Holdings Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CDIO relative to other companies in the Biotechnology industry. Currently, CDIO has a P/S ratio of 212.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CDIO in comparison with other companies in the Biotechnology industry. Currently, CDIO has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CDIO
Add Cardio Diagnostics Holdings Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CDIO